• Grazoprevir hydrate: From Protease Signal to Study Design

  2026-09-02

  Grazoprevir hydrate, also known as MK-5172 hydrate, is examined here through a translational lens: how NS3/4A inhibition, genotype-dependent potency, pharmacokinetics, and resistance biology should shape HCV research decisions. The article connects molecular activity with clinically relevant assay design without reducing the compound to a single EC₅₀ value.

• Pioglitazone Workflows for PPARγ Research

  2026-09-02

  Pioglitazone is a selective PPARγ agonist for connecting receptor activation with metabolic, macrophage, and tissue-protection readouts. This workflow-oriented guide translates published DSS colitis findings into practical cell, animal, and troubleshooting strategies for reproducible inflammatory and metabolic research.

• CIP2A–PKM2 Signaling Drives NSCLC Oxidative Metabolism

  2026-09-01

  The reference study identifies CIP2A as a metabolic regulator in non-small cell lung cancer, showing that it binds PKM2, promotes PKM2 tetramer formation, and redirects pyruvate metabolism toward mitochondrial oxidative phosphorylation. Its findings connect CIP2A, PKM2 phosphorylation at S287, mitochondrial localization, and Bcl2-dependent survival, while suggesting that combined CIP2A and glycolysis inhibition may provide a tractable experimental strategy.

• Selonsertib (GS-4997) for ASK1 Kidney Research

  2026-08-31

  Selonsertib, also called GS-4997, is an ATP-competitive ASK1 inhibitor for research on oxidative stress, p38/JNK signaling, inflammation, and fibrosis. A 2024 lupus nephritis study reported that GS-4997 reduced renal inflammation, fibrosis, and tubulointerstitial injury in MRL/lpr mice and LPS-stimulated HK-2 cells.

• Nigericin Workflows for pH and Ion-Transport Studies

  2026-08-31

  Nigericin provides a practical way to connect potassium/proton exchange with intracellular pH, mitochondrial stress, and cancer-cell vulnerability. This workflow-led guide shows how to prepare, dose, validate, and troubleshoot Nigericin experiments while using metabolism-focused findings from antibiotic-resistance research without overstating cross-domain evidence.

• GDC-0941 for PI3K/Akt Cancer Research

  2026-08-30

  GDC-0941 is a practical PI3K inhibitor for connecting rapid pAKT suppression with cancer cell proliferation inhibition, apoptosis assay results, and resistance biology. This workflow translates the DRD4–Akt/β-catenin findings in liver cancer into controlled, pathway-focused experiments while preserving clear limits between published evidence and proposed assay extensions.

• iPSC Cardiomyocytes for Chemical Hazard Prioritization

  2026-08-29

  Tsai and colleagues developed an integrated screening strategy that combines functional phenotypes, cytotoxicity, and transcriptomic responses in human iPSC-derived cardiomyocytes across 464 environmental chemicals and pharmaceuticals. The study shows that phenotype- and transcriptome-derived points of departure can support complementary hazard interpretation and exposure-based prioritization rather than relying on electrophysiology alone.

• SETD7 Depletion Promotes White Adipose Browning

  2026-08-29

  The reference study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis. Using genetic, cellular, metabolic, and transcriptomic approaches, the authors show that SETD7 depletion increases the Adcy7–Sirt1–CREB1 axis, enhances beige adipocyte activity, and protects obese mice from diet-induced metabolic deterioration.

• Tranexamic Acid Workflows for Clot Stability

  2026-08-28

  Tranexamic Acid provides a practical way to model inhibition of fibrinolysis, from plasmin assays to clot-stability and cell-adherence workflows. This guide translates the compound’s antifibrinolytic mechanism into reproducible bench experiments and shows how the same design logic supports advanced wound-dressing research.

• Moxidectin for Antifungal Synergy Workflows

  2026-08-28

  Moxidectin is best known as a macrocyclic lactone anthelmintic, yet recent research positions it as a mechanistically distinctive potentiator for polyene activity against Candida albicans. This guide translates that finding into practical microdilution, biofilm, sterol-analysis, and translational workflows while separating established veterinary use from exploratory antifungal research.

• Golgi-Tracker Green: From Signal to Mechanism

  2026-08-27

  Golgi-Tracker Green enables live-cell Golgi apparatus labeling with a BODIPY FL-labeled C5-ceramide design. This article presents an assay framework for connecting Golgi morphology, lipid trafficking, and mechanistic findings in cancer-cell studies without confusing correlation with causation.

• Macrophage EV miR-660 in Breast Cancer Metastasis

  2026-08-27

  The reference study identifies a macrophage-to-tumor communication mechanism in which extracellular vesicles transfer miR-660 to breast cancer cells and activate the KLHL21/IKKβ/NF-κB p65 axis. Its combined tissue, cell, extracellular-vesicle, and mouse-model evidence links this pathway to invasion and metastatic progression while highlighting experimental points for studying tumor microenvironment signaling.

• FLCN Mutations and mRNA Rescue in BHD Syndrome

  2026-08-26

  A 2026 study identified the novel FLCN nonsense variant p.Q44* and supplied segregation and functional evidence supporting pathogenic reclassification of p.W376R in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored folliculin expression and reduced abnormal mTORC1 signaling, providing an early in vitro rationale for protein-replacement research rather than a validated clinical therapy.

• SU 5402: From RTK Biology to Translational Models

  2026-08-26

  SU 5402 is more than a receptor tyrosine kinase inhibitor: it is a strategic perturbation tool for connecting pathway activity with phenotype. This article examines its mechanistic value in cancer biology and multiple myeloma research, then defines the evidence required before extending RTK studies into human iPSC-derived sensory neuron models of HSV-1 latency.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-25

  HRP Goat Anti-Rabbit IgG (H+L) Antibody provides an HRP-linked detection layer for rabbit primary antibodies in Western blotting, ELISA, IHC, and IC workflows. It is intended for research assay development and optimization, not diagnostic or medical use, and the supplied dossier does not establish assay-specific dilution, incubation, or performance values.

453 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page